NOVONIX Ltd Files 6-K, Confirms 20-F Filing
Ticker: NVNXF · Form: 6-K · Filed: Dec 19, 2024 · CIK: 1859795
Sentiment: neutral
Topics: sec-filing, 6-k, reporting
Related Tickers: NVX
TL;DR
NOVONIX filed a 6-K, confirming they'll use Form 20-F for annual reports. No major news.
AI Summary
NOVONIX Limited filed a Form 6-K on December 19, 2024, reporting its status as a foreign private issuer. The filing indicates that the company will file its annual reports under Form 20-F. The report does not contain specific financial figures or operational updates beyond its filing status.
Why It Matters
This filing confirms NOVONIX's reporting structure with the SEC, indicating its adherence to regulations for foreign private issuers and its commitment to filing annual reports on Form 20-F.
Risk Assessment
Risk Level: low — The filing is procedural and confirms standard reporting requirements, not indicating any immediate operational or financial risks.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
- December 19, 2024 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing by NOVONIX Limited?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, filed for the month of December 2024.
Which form will NOVONIX Limited use for its annual reports?
NOVONIX Limited will file its annual reports under cover of Form 20-F.
Is NOVONIX Limited submitting the Form 6-K in paper format?
The filing indicates that NOVONIX Limited is not submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) or Rule 101(b)(7).
What is NOVONIX Limited's principal executive office address?
NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
What is the Commission File Number for NOVONIX Limited's SEC filings?
The Commission File Number for NOVONIX Limited is 001-41208.
Filing Stats: 196 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-12-19 08:30:02
Filing Documents
- nvx-6k-dec-24-12-19_trad.htm (6-K) — 18KB
- nvx-ex99_1.htm (EX-99.1) — 28KB
- img58969013_0.jpg (GRAPHIC) — 5KB
- 0000950170-24-138249.txt ( ) — 55KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: December 19, 2024